Добірка наукової літератури з теми "SARS-CoV-2 (SARS2)"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "SARS-CoV-2 (SARS2)".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "SARS-CoV-2 (SARS2)"
Harrington, Whitney E., Winnie Yeung, Ingrid A. Beck, Fred D. Mast, John Houck, Sheila Styrchak, Leslie R. Miller, et al. "Low rate of SARS-CoV-2 incident infection identified by weekly screening PCR in a prospective year-long cohort study." PLOS ONE 17, no. 9 (September 26, 2022): e0274078. http://dx.doi.org/10.1371/journal.pone.0274078.
Повний текст джерелаWarren, René L., and Inanc Birol. "Interactive SARS-CoV-2 mutation timemaps." F1000Research 10 (February 3, 2021): 68. http://dx.doi.org/10.12688/f1000research.50857.1.
Повний текст джерелаWarren, René L., and Inanc Birol. "Interactive SARS-CoV-2 mutation timemaps." F1000Research 10 (June 3, 2021): 68. http://dx.doi.org/10.12688/f1000research.50857.2.
Повний текст джерелаO’Donnell, Kyle L., Tylisha Gourdine, Paige Fletcher, Kyle Shifflett, Wakako Furuyama, Chad S. Clancy, and Andrea Marzi. "VSV-Based Vaccines Reduce Virus Shedding and Viral Load in Hamsters Infected with SARS-CoV-2 Variants of Concern." Vaccines 10, no. 3 (March 12, 2022): 435. http://dx.doi.org/10.3390/vaccines10030435.
Повний текст джерелаKibler, Karen V., Mateusz Szczerba, Douglas Lake, Alexa J. Roeder, Masmudur Rahman, Brenda G. Hogue, Lok-Yin Roy Roy Wong, Stanley Perlman, Yize Li, and Bertram L. Jacobs. "Intranasal Immunization with a Vaccinia Virus Vaccine Vector Expressing Pre-Fusion Stabilized SARS-CoV-2 Spike Fully Protected Mice against Lethal Challenge with the Heavily Mutated Mouse-Adapted SARS2-N501YMA30 Strain of SARS-CoV-2." Vaccines 10, no. 8 (July 23, 2022): 1172. http://dx.doi.org/10.3390/vaccines10081172.
Повний текст джерелаLiu, Ying, Lu Li, Khalid A. Timani, and Johnny J. He. "A Unique Robust Dual-Promoter-Driven and Dual-Reporter-Expressing SARS-CoV-2 Replicon: Construction and Characterization." Viruses 14, no. 5 (May 5, 2022): 974. http://dx.doi.org/10.3390/v14050974.
Повний текст джерелаRoyal, Joshua M., Carrie A. Simpson, Alison A. McCormick, Amanda Phillips, Steve Hume, Josh Morton, John Shepherd, et al. "Development of a SARS-CoV-2 Vaccine Candidate Using Plant-Based Manufacturing and a Tobacco Mosaic Virus-like Nano-Particle." Vaccines 9, no. 11 (November 17, 2021): 1347. http://dx.doi.org/10.3390/vaccines9111347.
Повний текст джерелаRodrigues, Rui, and Sofia Costa de Oliveira. "The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression Levels in Patients with Comorbidities on COVID-19 Severity: A Comprehensive Review." Microorganisms 9, no. 8 (August 9, 2021): 1692. http://dx.doi.org/10.3390/microorganisms9081692.
Повний текст джерелаSeibert, Brittany, C. Joaquín Cáceres, Silvia Carnaccini, Stivalis Cardenas-Garcia, L. Claire Gay, Lucia Ortiz, Ginger Geiger, Daniela S. Rajao, Elizabeth Ottesen, and Daniel R. Perez. "Pathobiology and dysbiosis of the respiratory and intestinal microbiota in 14 months old Golden Syrian hamsters infected with SARS-CoV-2." PLOS Pathogens 18, no. 10 (October 24, 2022): e1010734. http://dx.doi.org/10.1371/journal.ppat.1010734.
Повний текст джерелаWang, Jiong, Bridget E. Young, Dongmei Li, Antti Seppo, Qian Zhou, Alexander Wiltse, Anna Nowak-Wegrzyn, et al. "Broad Cross-Reactive IgA and IgG against Human Coronaviruses in Milk Induced by COVID-19 Vaccination and Infection." Vaccines 10, no. 6 (June 20, 2022): 980. http://dx.doi.org/10.3390/vaccines10060980.
Повний текст джерелаДисертації з теми "SARS-CoV-2 (SARS2)"
Daff, Kaitlyn M. "Nutritional Implications in SARS-CoV-2." Youngstown State University / OhioLINK, 2020. http://rave.ohiolink.edu/etdc/view?acc_num=ysu1596622611336371.
Повний текст джерелаDafalla, Israa Yahia Al Hag Ibrahim. "Improving SARS-CoV-2 analyses from wastewater." Thesis, Högskolan i Skövde, Institutionen för biovetenskap, 2021. http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-20237.
Повний текст джерелаVareschi, Rodolfo Dimitrius. "Cloud computing adoption during SARS-COV-2 pamdemic." Master's thesis, Instituto Superior de Economia e Gestão, 2021. http://hdl.handle.net/10400.5/21746.
Повний текст джерелаDue to the rapid global spread of the pandemic caused by the new coronavirus, companies and institutions were forced to take precautionary measures to reduce the risk of contagion, such as asking employees to work remotely from their homes. In this scenario, cloud computing technology has proven to be a great ally of companies to overcome the crisis caused by the pandemic.The adoption of Cloud Computing technology has accelerated in recent years and, according to a forecast made by the International Data Corporation (IDC), investment in cloud services will exceed US $ 1.0 trillion in 2024, which represents a rate of annual growth of 15.7% (Villars et al., 2020).In an attempt to help organizations plan their strategies for adopting cloud computing, the present study intends to contribute to the existing literature on the subject, aiming to identify the main factors that influence the adoption of such technology during the Covid-19 pandemic crises.For this purpose, 18 factors identified during the literature review and were presented to 11 experts in the field of cloud computing technology, in order to seek a consensus regarding the order of importance of these factors.Through the Delphi method, divided into two phases and with two rounds, a list was obtained, ordered according to the degree of importance of the main factors that influence the adoption of cloud computing. After analyzing the data, the results obtained show that the six most important factors are: (1) Adoption, Migration and Acquisition Cost; (2) Availability and Accessibility; (3) Scalability; (4) Cost of Data Confidentiality and Availability Loss; (5) Security and (6) Customization.
Devido à rápida disseminação global da pandemia causada pelo novo coronavírus, empresas e instituições foram forçadas a tomar medidas de precaução para reduzir o risco de contágio, como pedir aos funcionários que trabalhassem remotamente das suas casas. Nesse cenário, a tecnologia de computação em nuvem tem se mostrado uma grande aliada das empresas para superar a crise provocada pela pandemia.A adoção de Computação em Nuvem tem se acelerado nos últimos anos e, segundo previsão da International Data Corporation (IDC), os investimentos em serviços em nuvem ultrapassarão US $ 1,0 milhão de bilhões em 2024, o que representa uma taxa de crescimento anual de 15,7% (Villars et al., 2020).Na tentativa de auxiliar as organizações no planeamento das suas estratégias de adoção da computação em nuvem, o presente estudo pretende contribuir com a literatura existente sobre o assunto, e tem como objetivo de identificar os principais fatores que influenciam a adoção dessa tecnologia durante a crise pandêmicas de Covid-19.Nesse sentido, 18 fatores identificados durante a revisão da literatura foram apresentados a 11 especialistas na área de tecnologia de computação em nuvem, a fim de encontrar um consenso quanto à ordem de importância desses fatores.Através do método Delphi, dividido em duas fases e com duas rondas, foi obtida uma lista ordenada de acordo com o grau de importância dos principais fatores que influenciam a adoção da computação em nuvem. Após a análise dos dados, os resultados obtidos mostram que os seis fatores mais importantes são: (1) Custo de Adoção, Migração e Aquisição; (2) Disponibilidade e acessibilidade; (3) Escalabilidade; (4) Custo de perda de confidencialidade e disponibilidade de dados; (5) Segurança e (6) Personalização.
info:eu-repo/semantics/publishedVersion
Колюбакіна, Л. В., О. В. Власова та Н. М. Крецу. "Kлініко-параклінічні особливості SARS-Cov-2 у новонароджених". Thesis, БДМУ, 2021. http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/18391.
Повний текст джерелаElfström, Mia. "Synthesis of SARS-CoV-2 Main Protease Inhibitors." Thesis, Uppsala universitet, Läkemedelsdesign och läkemedelsutveckling, 2021. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-449953.
Повний текст джерелаBălan, Mirela. "Integrative bioinformatic analysis of SARs-CoV-2 data." Thesis, Uppsala universitet, Institutionen för cell- och molekylärbiologi, 2021. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-450821.
Повний текст джерелаPhan, Alexandra. "Identification of MMP-9 as a Driving Factor in SARS-CoV-2 Entry." Thesis, Université d'Ottawa / University of Ottawa, 2021. http://hdl.handle.net/10393/42771.
Повний текст джерелаBui, Xuan Klaudia. "Biosensori FET per il rilevamento del SARS-CoV-2." Bachelor's thesis, Alma Mater Studiorum - Università di Bologna, 2020.
Знайти повний текст джерелаFlygare, Agnes. "The synthesis of main protease inhibitorsagainst SARS-CoV-2." Thesis, Uppsala universitet, Preparativ läkemedelskemi, 2021. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-448451.
Повний текст джерелаPisil, Yalcin. "The Study on Neutralization of Human Immunodeficiency Virus and SARS CoV-2 - Neutralization Resistance of SHIV and Neutralization Assay for SARS CoV-2 -." Doctoral thesis, Kyoto University, 2021. http://hdl.handle.net/2433/264673.
Повний текст джерела新制・課程博士
博士(人間・環境学)
甲第23392号
人博第1005号
新制||人||237(附属図書館)
京都大学大学院人間・環境学研究科相関環境学専攻
(主査)准教授 三浦 智行, 教授 川本 卓男, 准教授 西川 完途
学位規則第4条第1項該当
Doctor of Human and Environmental Studies
Kyoto University
DFAM
Книги з теми "SARS-CoV-2 (SARS2)"
Legach, Fr archpriest Evgeny I., and Konstantin S. Sharov, eds. SARS-CoV-2 and Coronacrisis. Singapore: Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-16-2605-0.
Повний текст джерелаGoswami, Srijan, and Chiranjeeb Dey. COVID-19 and SARS-CoV-2. Boca Raton: CRC Press, 2022. http://dx.doi.org/10.1201/9781003178514.
Повний текст джерелаShelton-Davenport, Marilee, Julie Pavlin, Jennifer Saunders, and Amanda Staudt, eds. Airborne Transmission of SARS-CoV-2. Washington, D.C.: National Academies Press, 2020. http://dx.doi.org/10.17226/25958.
Повний текст джерелаFocosi, Daniele. SARS-CoV-2 Spike Protein Convergent Evolution. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-87324-0.
Повний текст джерелаMueller, Siguna. Challenges and Opportunities of mRNA Vaccines Against SARS-CoV-2. Cham: Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-18903-6.
Повний текст джерелаPrabha, S., P. Karthikeyan, K. Kamalanand, and N. Selvaganesan. Computational Modelling and Imaging for SARS-CoV-2 and COVID-19. Boca Raton: CRC Press, 2021. http://dx.doi.org/10.1201/9781003142584.
Повний текст джерелаBerezina, Natal'ya, Mihail Cherkashin, and Nikita Berezin. Rational use of personal protective equipment in medical organizations in an unfavorable epidemiological situation ... ru: INFRA-M Academic Publishing LLC., 2020. http://dx.doi.org/10.12737/1215689.
Повний текст джерелаBerezina, Natal'ya, Mihail Cherkashin, Vladimir Kuplevackiy, Dar'ya Kuplevackaya, Tat'yana Rakova, Aleksey Nikolaev, Artem Fedorov, and Anna Lavrent'eva. Organization of the work of the outpatient computer tomography center to provide emergency care to patients with suspected new coronavirus infection. ru: INFRA-M Academic Publishing LLC., 2021. http://dx.doi.org/10.12737/1222384.
Повний текст джерелаPennella, Valentino. SARS-CoV-2. Independently Published, 2020.
Знайти повний текст джерелаPennella, Valentino. SARS-CoV-2. Independently Published, 2020.
Знайти повний текст джерелаЧастини книг з теми "SARS-CoV-2 (SARS2)"
Focosi, Daniele. "SARS-CoV-2 Variants." In SpringerBriefs in Microbiology, 55–71. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-87324-0_6.
Повний текст джерелаNowak-Far, Artur. "SARS-CoV-2 pandemic." In Contemporary States and the Pandemic, 69–87. London: Routledge India, 2022. http://dx.doi.org/10.4324/9781003353805-5.
Повний текст джерелаYadav, Tushar, and Shailendra K. Saxena. "Transmission Cycle of SARS-CoV and SARS-CoV-2." In Medical Virology: From Pathogenesis to Disease Control, 33–42. Singapore: Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-15-4814-7_4.
Повний текст джерелаSokolova, Svetlana N., and Anastasia A. Sokolova. "Radical Changes of Information Society During SARS-CoV-2 Pandemic and Structural Transformations of the Security Sphere: Experience of Republic of Belarus." In SARS-CoV-2 and Coronacrisis, 195–206. Singapore: Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-16-2605-0_13.
Повний текст джерелаSharov, Konstantin S. "SARS-CoV-2 in Acute Respiratory Infection Situation in Russia in Spring–Summer 2020." In SARS-CoV-2 and Coronacrisis, 55–66. Singapore: Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-16-2605-0_4.
Повний текст джерелаGerilovych, Fr priest Anton P., Borys T. Stegniy, Larysa V. Kovalenko, Yurii K. Dunaiev, Natalia S. Rodyna, Oksana V. Kinash, Vasiliy L. Arefiev, et al. "SARS-CoV-2 Zoonotic Potential: Current Knowledge and Hypotheses." In SARS-CoV-2 and Coronacrisis, 37–54. Singapore: Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-16-2605-0_3.
Повний текст джерелаLegach, Fr archpriest Evgeny I., Galyna A. Bozhok, and Konstantin S. Sharov. "Using Experience in Previous Epidemics for Effective Containing SARS-CoV-2: Spanish Influenza 1918 and Beyond." In SARS-CoV-2 and Coronacrisis, 3–16. Singapore: Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-16-2605-0_1.
Повний текст джерелаSassin, Wolfgang. "Coronacrisis Reconstruction Programmes: Saving the “Global Economy”?" In SARS-CoV-2 and Coronacrisis, 221–48. Singapore: Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-16-2605-0_15.
Повний текст джерелаDuna, Nataliia G. "Managing Economic, Cultural and Mental Crises Caused by COVID-19 Pandemic." In SARS-CoV-2 and Coronacrisis, 279–89. Singapore: Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-16-2605-0_18.
Повний текст джерелаMoskovkin, Vladimir M., Tatyana V. Saprykina, and Igor V. Boichuk. "Phenomenon of Coronavirus Publication Race." In SARS-CoV-2 and Coronacrisis, 311–77. Singapore: Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-16-2605-0_20.
Повний текст джерелаТези доповідей конференцій з теми "SARS-CoV-2 (SARS2)"
Ay, Emrah, and Nizami Duran. "Resistance of SARS CoV-2 to Seawater." In The 9th International Conference on Advanced Materials and Systems. INCDTP - Leather and Footwear Research Institute (ICPI), Bucharest, Romania, 2022. http://dx.doi.org/10.24264/icams-2022.iii.2.
Повний текст джерелаLazarus, Theophilus. "SARS-CoV-2 infection and neuropsychological outcomes." In 2nd International Neuropsychological Summer School named after A. R. Luria “The World After the Pandemic: Challenges and Prospects for Neuroscience”. Ural University Press, 2020. http://dx.doi.org/10.15826/b978-5-7996-3073-7.10.
Повний текст джерела"APPLICATIONS OF SARS-COV-2 SEQUENCING DATA." In 14th International Conference on Computer Graphics, Visualization, Computer Vision and Image Processing. IADIS Press, 2020. http://dx.doi.org/10.33965/bigdaci2020_202011c034.
Повний текст джерелаRivas Rodríguez, MD, RM Medina Comas, C. Redondo Galán, M. Ferris Villanueva, D. González Vaquero, and JF Rangel Mayoral. "4CPS-388 Telepharmacy during SARS-CoV-2." In 25th Anniversary EAHP Congress, Hospital Pharmacy 5.0 – the future of patient care, 23–28 March 2021. British Medical Journal Publishing Group, 2021. http://dx.doi.org/10.1136/ejhpharm-2021-eahpconf.220.
Повний текст джерелаHatzipanagiotou, Maria, Miriam Fernandez, Rahel Deborah Huber, Olaf Ortmann, and Ute Germer. "Maternofetale Transmission bei Sars-CoV-2 Virusinfektion." In Interdisziplinärer Kongress | Ultraschall 2022. Georg Thieme Verlag, 2022. http://dx.doi.org/10.1055/s-0042-1749557.
Повний текст джерелаFerreira, Caíque Levir da Silva, Bárbara Guimarães Silqueira, Vanessa Giovanini Gasparoto, Ana Laura de Souza Campiello Talarico, and Ana Caroline Vendrame Cazeloto. "MANIFESTAÇÕES NEUROLÓGICAS CAUSADAS PELO SARS-COV-2." In III Congresso Online de Neurocirurgia e Neurologia. Congresse.me, 2022. http://dx.doi.org/10.54265/cnlc1334.
Повний текст джерелаChen, Zhitong. "Cold Plasma for SARS-CoV-2 Inactivation." In 2021 IEEE International Conference on Plasma Science (ICOPS). IEEE, 2021. http://dx.doi.org/10.1109/icops36761.2021.9588571.
Повний текст джерелаPavitt, Matthew, Sophie Krivinskas, Jo Congleton, and Sabrine Hippolyte. "SARS-CoV-2: Survival in COPD phenotypes." In ERS International Congress 2021 abstracts. European Respiratory Society, 2021. http://dx.doi.org/10.1183/13993003.congress-2021.oa4195.
Повний текст джерелаEmi Aikawa, Nádia, Léonard de Vinci Kanda Kupa, Sandra Gofinet Pasoto, Ana Cristina de Medeiros Ribeiro, Emily Figueiredo Neves Yuki, Carla Gonçalves Schahin Saad, Tatiana Pedrosa, et al. "DYNAMICS OF INACTIVATED SARS-COV-2 VACCINE ANTIBODY RESPONSE IN SARS-COV-2-SEROPOSITIVE AUTOIMMUNE RHEUMATIC DISEASE PATIENTS." In SBR 2021 Congresso Brasileiro de Reumatologia. Sociedade Brasileira de Reumatologia, 2021. http://dx.doi.org/10.47660/cbr.2021.1905.
Повний текст джерелаSmatti, Maria K., Yasser Al-Sarraj, Omar Albagha, and Hadi M. Yassine. "Host Genetic Variants Potentially Associated with SARS-Cov-2: A Multi-Population Analysis." In Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2020. http://dx.doi.org/10.29117/quarfe.2020.0298.
Повний текст джерелаЗвіти організацій з теми "SARS-CoV-2 (SARS2)"
Urbatsch, Dana. Monitoring SARS-CoV-2 in wastewater. Office of Scientific and Technical Information (OSTI), July 2022. http://dx.doi.org/10.2172/1878019.
Повний текст джерелаUrbatsch, Dana. Monitoring SARS-CoV-2 in wastewater. Office of Scientific and Technical Information (OSTI), August 2022. http://dx.doi.org/10.2172/1881788.
Повний текст джерелаPaul, Satashree. Crosstalk Between Lung Cancer and SARS-CoV-2. Edited by Nature Library. Nature Library, September 2020. http://dx.doi.org/10.47496/nl.blog.06.
Повний текст джерелаGleasner, Cheryl, Kimberly Mcmurry, Julia Kelliher, and Andrew Hatch. Illumina Sequencing for SARS-CoV-2 Training [Slides]. Office of Scientific and Technical Information (OSTI), May 2021. http://dx.doi.org/10.2172/1782612.
Повний текст джерелаJüni, Peter, Antonina Maltsev, Pavlos Bobos, Upton Allen, Yoojin Choi, James P. Connell, Gerald A. Evans, et al. The Role of Children in SARS-CoV-2 Transmission. Ontario COVID-19 Science Advisory Table, August 2020. http://dx.doi.org/10.47326/ocsat.2020.01.03.1.0.
Повний текст джерелаSola, Isabel. Estrategias para controlar al nuevo coronavirus SARS-Cov-2. Sociedad Española de Bioquímica y Biología Molecular, March 2020. http://dx.doi.org/10.18567/sebbmdiv_actu.2020.03.1.
Повний текст джерелаNegrete, Oscar, Steven Bradfute, Steven Larson, Anupama Sinha, Kenneth Coombes, Ronald Goeke, Lisa Keenan, et al. Photocatalytic Material Surfaces for SARS-CoV-2 Virus Inactivation. Office of Scientific and Technical Information (OSTI), September 2020. http://dx.doi.org/10.2172/1669200.
Повний текст джерелаChan, Wanyu. SARS-CoV-2 Transmission Control in California Correctional Facilities. Office of Scientific and Technical Information (OSTI), October 2022. http://dx.doi.org/10.2172/1891334.
Повний текст джерелаLeitner, Thomas. Tracking the SARS-CoV-2 Epidemic Using the Evolutionary Rate. Office of Scientific and Technical Information (OSTI), September 2020. http://dx.doi.org/10.2172/1659156.
Повний текст джерелаGans, Joshua. Test Sensitivity for Infection versus Infectiousness of SARS-CoV-2. Cambridge, MA: National Bureau of Economic Research, September 2020. http://dx.doi.org/10.3386/w27780.
Повний текст джерела